A cannabis drug offers new hope to thousands of Britons with untreatable forms of epilepsy, a groundbreaking study has shown. The cannabidiol compound, Epidiolex, has been developed by Histon-based GW Pharmaceuticals. It was shown to reduce convulsive seizures by nearly 40 per cent in teenagers and children with Dravet syndrome, a rare and severe epileptic […]